Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 39 Neoplasms 37 Depression 29 Prostatic Neoplasms 23 Fatigue 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Multiple Myeloma 15 Lymphoma, Follicular 15 Lymphoma, Large B-Cell, Diffuse 13 Carcinoma, Non-Small-Cell Lung 13 Anxiety Disorders 13 Lymphoma, Mantle-Cell 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Burkitt Lymphoma 12 Pain 11 Lymphoma, Non-Hodgkin 11 Lymphoma, B-Cell, Marginal Zone 11 Lung Neoplasms 11 Lymphoma, Large-Cell, Immunoblastic 10 Leukemia, Myeloid, Acute 10 Colorectal Neoplasms 10 Leukemia, Myeloid, Chronic-Phase 9 Hodgkin Disease 9 Blast Crisis 9 Vomiting 8 Nausea 8 Lymphoma 8 Leukemia, Myeloid, Accelerated Phase 8 Head and Neck Neoplasms 8 Uterine Cervical Neoplasms 7

Interventions

Gemcitabine 9 pembrolizumab 7 Cisplatin 5 enfortumab vedotin 4 atezolizumab 4 Trastuzumab 4 Carboplatin 4 Sunitinib 3 Pemetrexed 3 Mitomycin 3 cabozantinib 2 Water 2 Sugammadex 2 Standard of Care 2 Saline Solution 2 Paclitaxel 2 Nivolumab 2 Neostigmine 2 Docetaxel 2 Cetuximab 2 Bevacizumab 2 zidovudine 5'-monophosphate-mannose-albumin conjugate 1 vinflunine 1 valrubicin 1 tucatinib 1 tislelizumab 1 testosterone 17 beta-cypionate 1 temsirolimus 1 relatlimab 1 poly ICLC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Urologic Neoplasms × Therapeutics × Clear all

NCT05038657 2022-10-03

AURORA

University Hospital Southampton NHS Foundation Trust

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡